The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Yeshwant Krishna since 2014.
This trader's CIK number is 1585001.
At the time of last reporting, Yeshwant Krishna was the Officer of Verve Therapeutics, Inc.. (stock ticker symbol VERV).
Also see all insider trading activities at Verve Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | VERV | 1,800,000 | $18,000,000 | 0 | $0 | 0 | $0 |
| 2022 | VERV | 0 | $0 | 212,462 | $7,547,027 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | FMI | 0 | $0 | 22,872 | $858,001 | 13,385 | $324,050 |
| 2015 | FMI | 0 | $0 | 192,460 | $6,394,673 | 0 | $0 |
| 2014 | FMI | 0 | $0 | 1,300,000 | $29,120,000 | 0 | $0 |
1. Verve Therapeutics, Inc. (VERV)
2. Foundation Medicine, Inc. (FMI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-01 | VERV | Buy | 1,800,000 | 10.00 | 18,000,000 |
| 2022-11-04 | VERV | Sale | 48,583 | 32.00 | 1,554,801 |
| 2022-11-03 | VERV | Sale | 49,568 | 33.10 | 1,640,552 |
| 2022-11-02 | VERV | Sale | 28,652 | 35.94 | 1,029,838 |
| 2022-10-31 | VERV | Sale | 53,696 | 39.41 | 2,116,320 |
| 2022-11-01 | VERV | Sale | 31,963 | 37.72 | 1,205,516 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-08-08 | FMI | Sale | 4,800 | 40.01 | 192,048 |
| 2017-08-04 | FMI | Option Ex | 13,385 | 24.21 | 324,050 |
| 2017-08-04 | FMI | Sale | 18,072 | 36.85 | 665,953 |
| 2015-06-15 | FMI | Sale | 114,481 | 32.33 | 3,701,170 |
| 2015-06-11 | FMI | Sale | 15,734 | 35.14 | 552,892 |
| 2015-06-12 | FMI | Sale | 53,645 | 33.72 | 1,808,909 |
| 2015-05-14 | FMI | Sale | 8,600 | 38.57 | 331,702 |
| 2014-06-13 | FMI | Sale | 1,300,000 | 22.40 | 29,120,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yeshwant Krishna (Officer of Verve Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.